Sign In
Buy BIO
$304.83
-1.30 (-0.425%)
At Close: Jun 03, 2026
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
05:24pm, Thursday, 21'st Oct 2021
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Bio-Rad (BIO) Stock For Now
11:40am, Wednesday, 20'th Oct 2021
Investors are optimistic about Bio-Rad (BIO) on solid international market performance and raised 2021 guidance.
Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021
08:00am, Friday, 15'th Oct 2021
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the thi
Bio Rad (BIO) Global Growth Strong, Expenses Continue to Rise
02:56pm, Thursday, 30'th Sep 2021
Bio Rad (BIO) is witnessing strong growth in the biopharma market, riding on the Droplet Digital PCR platform.
A Trio of Stocks for Growth-Oriented Investors
02:39pm, Thursday, 16'th Sep 2021
Growth-oriented investors may want to consider the following stocks since they represent businesses with price-earnings ratios below 20 and recorded significant improvements in trailing 12-month earni
Bio-Rad (BIO) Upgraded to Strong Buy: Here's Why
01:44pm, Thursday, 16'th Sep 2021
Bio-Rad (BIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know
01:44pm, Tuesday, 14'th Sep 2021
Does Bio-Rad Laboratories (BIO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Now
11:11am, Monday, 13'th Sep 2021
Investors are optimistic about Bio-Rad (BIO) on solid international market performance and raised 2021 guidance.
What Makes Bio-Rad (BIO) a Good Fit for "Trend Investing"
09:54am, Tuesday, 31'st Aug 2021
Bio-Rad (BIO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference
08:00am, Tuesday, 31'st Aug 2021
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that management will part
New Analyst Coverage Puts Spotlight on These 5 Stocks
11:29am, Thursday, 26'th Aug 2021
Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like NBTB, BIO, RDNT, ABR and CATY.
This Unknown Biotech Has a Secret Weapon for Outsized Returns
07:19am, Saturday, 21'st Aug 2021
Bio-Rad's equity position in a German pharma company is an asset many investors may not realize.
5 Stocks With Recent Price Strength Amid Robust Reopening
09:59am, Thursday, 19'th Aug 2021
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength like VRTV, LCUT, GRIN, CMRE and BIO have a high chance of carrying the momentum forward.
Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It?
12:10pm, Tuesday, 17'th Aug 2021
Strong performance across the Life Science and Clinical Diagnostics businesses drove the top line for Bio-Rad (BIO).
Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock
02:04pm, Wednesday, 11'th Aug 2021
Bio-Rad (BIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
